Airway Protection Rehabilitation for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to assist people with Parkinson's Disease (PD) who struggle to protect their airways, potentially leading to serious lung issues. The study will test a new treatment involving Expiratory Muscle Strength Training (EMST) and Cough Skill Training, which are breathing and coughing exercises, delivered either in-person or through telehealth. It seeks participants with PD who have swallowing or coughing difficulties and are not currently receiving exercise-based therapy for swallowing. Participants must live within 1.5 hours of the study locations and meet other specific health criteria. This research aims to make effective treatments more accessible to people with PD. As a Phase 2 trial, it focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant advancements in PD care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Expiratory Muscle Strength Training (EMST) combined with Cough Skill Training is safe for people with Parkinson's Disease. These treatments improve airway protection without major side effects.
One study found that participants increased their ability to exhale forcefully by 19% after using EMST. This improvement, known as Maximum Expiratory Pressure (MEP), indicates that the treatment is effective and well-tolerated. No serious side effects related to the treatment were reported.
Overall, these findings suggest that this treatment approach is safe for those with Parkinson's Disease. It focuses on strengthening the muscles used for breathing and coughing, which can help prevent issues like aspiration pneumonia.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for Parkinson's disease because they focus on enhancing airway protection, which is a critical issue for many patients. Unlike standard treatments that mainly address motor symptoms, Expiratory Muscle Strength Training coupled with Cough Skill Training targets the muscles involved in breathing and coughing. This approach not only aims to improve respiratory function but also offers the convenience of being delivered in-person or via telehealth, making it accessible to more patients. By strengthening the muscles involved in expiration and coughing, these methods have the potential to significantly reduce the risk of aspiration and related complications.
What evidence suggests that this trial's treatments could be effective for airway protection in Parkinson's Disease?
Research has shown that Expiratory Muscle Strength Training (EMST) can greatly improve breathing and swallowing for people with Parkinson's Disease. Studies have found that EMST strengthens and enhances coughing, which helps protect the airway. This is crucial because problems with airway protection can lead to serious issues like pneumonia, a leading cause of death in people with Parkinson's. In this trial, participants will receive either in-person or telehealth delivery of the combined EMST and Cough Skill Training. Combining EMST with Cough Skill Training might enhance these benefits by teaching patients how to clear their airways better. Early research suggests this combined approach is a promising way to manage airway protection problems in Parkinson's Disease.26789
Who Is on the Research Team?
Michelle Troche, PhD
Principal Investigator
Teachers College, Columbia University
Are You a Good Fit for This Trial?
This trial is for people aged 50-90 with Parkinson's Disease who have trouble swallowing or coughing but aren't currently getting therapy for it. They must be diagnosed by a specialist and can't have other neurological disorders, recent smoking history, breathing diseases, severe depression or dementia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intensive Treatment
Participants undergo four weeks of intensive Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) delivered in-person or via telehealth
Maintenance Treatment
Participants continue with a long-term EMST+CST maintenance program offered in-person or via telehealth
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Expiratory Muscle Strength Training + Cough Skill Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Teachers College, Columbia University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Purdue University
Collaborator